ArticleBlood advances2019

Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B.

Annette Von Drygalski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.